Pharma and medtech invest billions in clinical research, yet inefficiencies in site and investigator selection delay trials and inflate costs. Discover how AI-driven insights and real-time data can optimize trial site feasibility, improve patient recruitment, and accelerate time to market.
Month: February 2025
Quantifying Early-Stage R&D Inefficiencies: A Strategic Opportunity
Pharma and medtech invested $238 billion in R&D in 2022—but inefficiencies in early-stage collaboration with HCPs and KOLs are driving costs up and slowing innovation. Discover how Meplis helps optimize R&D collaboration to maximize ROI.